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The surgical treatment of primary varicose veins
associated with greater saphenous vein (GSV) reflux
has evolved into high ligation of the GSV, with liga-
tion and resection of all tributaries entering the
saphenofemoral junction (SFJ) and stripping of the
thigh portion of the GSV, with stab-avulsion phle-
bectomy of clusters fed by incompetent perforating
veins.1-3 Because the GSV itself is rarely varicose,
some have objected to inclusion of the thigh
saphenectomy, believing it to be unnecessarily trau-
matic and wasteful of a valuable potential arterial
substitute.4-6 These objections are more than offset
by the combined results of six prospective random-
ized studies showing that the GSV stripping reduces
recurrence of both reflux and varicosities from 50%
or greater after high ligation without saphenectomy
to 26% to 28% in limbs followed for 2 to 5 years.7-12
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Objective: This study explores the added effect of extended saphenofemoral junction (SFJ)
ligation when the greater saphenous vein (GSV) has been eliminated from participating
in thigh reflux by means of endovenous obliteration. GSV obliteration, unlike surgical
stripping, can be done with or without SFJ ligation to isolate and study SFJ ligation’s
specific contribution to treatment results.
Methods: Sixty limbs treated with SFJ ligation and 120 limbs treated without high liga-
tion were selected from an ongoing, multicenter, endovenous obliteration trial on the
basis of their having primary varicose veins, GSV reflux, and early treatment dates.
Results: Five (8%) high-ligation limbs and seven (6%) limbs without high ligation with
patent veins at 6 weeks or less were excluded as unsuccessful obliterations. Treatment
significantly reduced symptoms and CEAP clinical class in both groups (P = .0001).
Recurrent reflux developed in one (2%) of 49 high-ligation limbs and eight (8%) of 97
limbs without high ligation by 6 months (P = .273). New instances of reflux did not
appear thereafter in 57 limbs followed to 12 months. Recurrent varicose veins occurred
in three high-ligation limbs and four limbs without high ligation by 6 months and in
one additional high-ligation limb and two additional limbs without high ligation by 12
months. Actuarial recurrence curves were not statistically different with or without SFJ
ligation (P > .156), predicting greater than 90% freedom from recurrent reflux and vari-
cosities at 1 year for both groups.
Conclusion: These early results suggest that extended SFJ ligation may add little to effec-
tive GSV obliteration, but our findings are not sufficiently robust to warrant abandon-
ment of SFJ ligation as currently practiced in the management of primary varicose veins
associated with GSV vein reflux. (J Vasc Surg 2000;32:941-53.)
Studies of recurrent reflux around the SFJ in
patients with recurrent varicosities have shown that the
principal findings are a network of residual SFJ tribu-
taries connecting to more distal subcutaneous veins or
an intact GSV because the GSV was not stripped and
newly formed veins (neovascularization) were con-
necting the deep and superficial systems.12-14 These
findings have been interpreted as supporting the need
for removal of the thigh portion of the GSV and are
the basis of the concept of extended resection of SFJ
tributaries beyond their own primary tributaries to
effect a more thorough disconnection.1
In the decade since its proposal by Glass,15 evi-
dence has accumulated to support neovascularity,
which is regarded as an extension of groin wound–
healing angiogenesis, as a major source of new chan-
nels reconnecting superficial veins to the common
femoral vein around a divided SFJ.12,13,16 Cross-groin
newly formed veins have also been observed. These
link the superficial drainage of the lower abdomen and
pudendum to varicose thigh tributaries.16
The current study takes advantage of the fact
that GSV obliteration can be done without a groin
incision and without interrupting the normal
drainage of the superficial, inferior, epigastric vein;
the circumflex iliac vein; and the external pudendal
vein to explore a two-part hypothesis:
1. SFJ tributary ligation and resection may be of lit-
tle benefit in preventing recurrent reflux and
reappearance of varicosities if the thigh portion
of the GSV has been effectively eliminated.
2. Tributary ligation and resection, by interfering
with the venous drainage of lower abdominal and
pudendal tissues, may be an important stimulus
to new vessel formation. If this is true, SFJ tribu-
tary ligation could be counterproductive when
superimposed on successful GSV obliteration.
METHODS
Endovenous obliteration was done with the
Closure System (VNUS Medical Technologies, Inc,
Sunnyvale, Calif). The system consists of a dedicated,
microprocessor-controlled, bipolar generator and
catheters with collapsible electrodes that are intro-
duced into the vein lumen and then energized to
destroy the intima and contract the vein wall so that it
will undergo fibrous obliteration, as previously
described.17,18
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Table I. Choice of high ligation and no high liga-
tion by treating center
Center High ligation No high ligation % High ligation
1 6 22 21
2 0 13 0
3 10 1 91
4 0 11 0
5 10 0 100
6 0 10 0
7 1 8 11
8 8 0 100
9 7 0 100
10 0 7 0
11 0 7 0
12 0 7 0
13 0 6 0
14 2 4 33
15 5 0 100
16 1 4 20
17 0 5 0
18 4 0 100
19 0 4 0
20 1 2 33
21 0 3 0
22 0 3 0
23 and 24* 0 3 0
25-27* 5 0 100
Total 60 120 —
*Centers treating only one or two limbs.
Fig 1. SFJ anatomy. In this variant the superficial circumflex
iliac and inferior superficial epigastric veins have a common
trunk, which has been reported to occur in 15% of SFJs.27
AL, Anterolateral tributary; PM, posteromedial tributary;
SCI, superficial circumflex iliac vein; SE, inferior superficial
epigastric vein; SEP, superficial external pudendal vein.
The study patients were selected from an ongoing
multicenter trial of endovenous obliteration in
Europe, the United States, and Australia, which is
being conducted by the VNUS Closure-Treatment
Study Group (Appendix).17 To be considered for
inclusion, patients had to have primary venous insuf-
ficiency manifested by both a greater than 1-second
GSV reflux with a Valsalva or calf compression release
and readily visible varicosities. Patients with domi-
nant deep-system reflux or post-thrombotic changes
were excluded. Treatment dates were then used to
select the first 60 limbs treated with high ligation and
the first 120 limbs treated without high ligation from
the group of qualified limbs to allow the longest pos-
sible follow-up. The number of high-ligation limbs
was a limiting factor. Twice as many limbs without
high ligation were included to reach a sample size
that would have reasonable power to detect the
expected between-group differences in the principal
outcome variables and to add precision to the analy-
sis of the procedure with the greater deviation from
conventional ligation and stripping.
The election to use or not include SFJ ligation was
not randomized nor was it decided on a case-by-case
basis because of a particular SFJ anatomy. The choice
was based on investigator preference and, as shown in
Table I, was the same for most patients at an individ-
ual treatment center. Eighty-one percent of limbs were
treated at centers where all limbs or all but one limb
were treated in the same way with respect to inclusion
of SFJ ligation. Two centers were exceptions, numbers
1 and 14 in Table I. Center number 1 had two princi-
pal investigators, an interventional radiologist and a
surgeon, who were committed to percutaneously
accessing the GSV immediately below the knee. They
were unable to achieve percutaneous access in six of 28
limbs and resorted to a conventional groin incision to
access the GSV. Because the groin was now opened,
they thought that the patient would be best served by
adding SFJ ligation. In their own words, SFJ ligation
was simply a “side product” of the venous access prob-
lem. Center number 14 also had two principal investi-
gators, both surgeons. The first investigator, who
treated two limbs, was adamant that extended SFJ li-
gation was essential. The other investigator, who
treated four limbs, thought that avoiding a groin inci-
sion was a substantial advantage and decided, before
beginning the study, not to do high ligations.
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Table II. Cohort characteristics
Characteristic High ligation No high ligation P value
Mean age ± SD (y) 47 ± 11 47 ± 13 .885
Female predominance 46/60 (77%) 82/106 (77%) 1.00
CEAP clinical class* 2.3 ± 0.5 2.6 ± 0.9 .002
Mean symptom score† 1.9 ± 0.8 1.9 ± 0.9 .704
Treatment dates Jan 1998-May 1999 Oct 1998-Apr 1999 .538
Veins treated‡
Above-knee GSV 36 (60%) 95 (79%) .007
Entire GSV 24 25
Stab-avulsion phlebectomy 48 (80%) 73 (61%) .011
Early (≤ 6 wk) patency 5 (8%) 7 (6%) .538
No. of limbs eligible for 6-mo follow-up 55 113 —
No. of limbs eligible for 12-mo follow-up 51 80 —
*Clinical classification: 0, no visible or palpable signs of venous disease; 1, telangiectases, reticular veins, or malleolar flare; 2, varicose
veins; 3, edema without skin changes; 4, skin changes ascribed to venous disease (pigmentation, venous eczema, or lipodermatosclero-
sis); 5, skin changes with healed ulceration; and 6, skin changes with active ulceration.23
†One point each for pain, aching-fatigue, and swelling.
‡Above-knee indicates treating the thigh portion of the saphenous vein, beginning at the SFJ and terminating just below the popliteal
crease. Entire indicates treating from the SFJ to just above the ankle.
Table III. Complications
Complications High ligation No high ligation P value
Femoral-vein thrombus propagation 0 1 (0.8%) —
Paresthesias 15 (25%) 19 (16%) .159
Perivenous or dermal inflammation 9 (15%) 4 (3%) .011
Skin burns 2 (3%) 4 (3%) 1.00
SFJ ligation was generally understood to be per-
formed by completely dissecting the SFJ and dividing
the cribriform fascia to enable identification of the true
junction and its ligation flush with the common
femoral vein. The dissection was expected to reveal five
or more junctional tributaries (Fig 1). Each was to be
drawn into the wound until its own first tributary
could be ligated independently along with the main
tributary trunk. These principles were agreed on at
investigator meetings and in discussions with individ-
ual investigators. The protocol, however, focused on
the conduct and assessment of the endovenous oblit-
eration and did not impose a study-wide standardized
SFJ ligation procedure. As a consequence, the surgical
procedure steps that were actually performed were not
systematically assayed and were likely to have varied
according to individual investigators’ interpretations of
what constituted a comprehensive SFJ ligation.
Follow-up visits were programmed for 1 and 6
weeks and 3, 6, and 12 months to include a protocol-
governed history and clinical assessment in both the
recumbent and standing positions and color duplex
scanning of the groin and the entire length of
treated vein. Reflux testing was done with a Valsalva
maneuver with the patient tilted 15 degrees with his
or her head up or with calf compression release
while standing.19
The selected sample size provided 80% power to
detect a twofold difference in recurrence of reflux or
varicosities at the 0.05 significance level, assuming
20% recurrence rates for the more effective treat-
ment arm.20 The χ2 test or the Fisher exact test was
used to compare proportions. Unpaired continuous
and ordinal data were evaluated nonparametrically
by the use of the Kruskall-Wallis analysis of variance
by ranks, and paired comparisons were assessed with
the Wilcoxon signed-rank test.20 Actuarial event-
rate calculations were performed according to the
method described by Cutler and Ederer21 and com-
pared by the use of the log-rank test.22
RESULTS
Cohort comparability. Patient selection encom-
passed 128 women and 38 men ranging in age from
19 to 78 years. The characteristics of the two cohorts
are shown in Table II. The groups were well matched
in age, female predominance, and symptom scores,
but the limbs without high ligation had a higher pre-
treatment mean CEAP clinical class,23 which was
influenced by three limbs with healed ulcers and one
with an active ulcer. Treatment of the limbs without
high ligation was less likely to have incorporated
stab-avulsion phlebectomies and more likely to have
been restricted to the thigh portion of the GSV.
Five high-ligation limbs and seven limbs without
high ligation had a greater than 5-cm segment
reopening of treated vein within 6 weeks. These
were unsuccessful obliterations typically associated
with too rapid catheter withdrawal.17,18 These oblit-
eration failures were not considered further because
they bore no relevance to the study’s assessment of
the added effect of SFJ ligation when the GSV has
been effectively eliminated from the thigh. Their
subsequent course is shown in Fig 2, where it can be
seen that one limb in each group (20% and 14%,
respectively) was known to have developed both
recurrent reflux and new or recurrent varicosities.
The complication rates in Table III were similar
for thermal injuries to adjacent sensory nerves and
skin, but the effects of thermal spread to other
perivenous tissues and the deep dermis were more
common in the high-ligation group. The one
thrombus propagation into the common femoral
vein in a limb without high ligation would presum-
ably have been prevented by a properly performed,
flush high-ligation. More detailed descriptions of
complications encountered with endovenous oblit-
eration have been reported elsewhere.17,18
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Fig 2. Subsequent course of high-ligation veins and veins
without high ligation exhibiting early patency.
SFJ tributary patency and new vessel forma-
tion after endovenous obliteration with and
without high ligation. Fig 3 shows the duplex
scanning–guided positioning of the catheter at the
SFJ and the acute occlusion of a tributary orifice
covered by the expanded electrodes. Fig 4 shows
persistent patency of an SFJ tributary despite
catheter positioning as in Fig 3, B, with no GSV
flow, and Fig 5 shows patency of two formerly
occluded SFJ tributaries with unimpeded flow into
the common femoral vein and persistent GSV occlu-
sion. These color-flow duplex scan images were
made at one investigative site where SFJ duplex scan
anatomy was studied serially in 15 limbs with termi-
nal- or subterminal-valve incompetence treated by
endovenous obliteration without high ligation.24
Duplex scanning was used during treatment to posi-
tion the electrodes exactly as shown in Fig 3, B. The
posttreatment results in this substudy are shown dia-
grammatically in Fig 6. A third of the limbs showed
complete SFJ obliteration at 1 week, including the
limb noted in Table III to have femoral vein throm-
bus propagation. By 6 months, only one SFJ
remained completely occluded; the other 14 (93%)
had at least one open tributary with prograde SFJ
flow. Nearly two thirds of the limbs with patent trib-
utaries had a 1- to 2-cm GSV stump serving as a
conduit for tributary flow. The upper end of the
GSV obliteration was sculpted by tributary flow to
form a smooth curved path to the SFJ without fur-
ther intrusion on the obliterated contracted GSV
below the open tributary orifices, as shown in the
third drawing in Fig 6.
In the overall study color duplex scanning
demonstrated one or more patent SFJ tributaries
with normal prograde flow through the SFJ in 34
(35%) of 97 limbs without high ligation followed for
6 or more months, which was a significantly (P =
.0001) greater proportion than the three limbs (6%)
with patent SFJ tributaries found among the 49
limbs with high ligation. The external pudendal vein
was the most commonly identified open tributary
seen by itself or in association with other patent trib-
utaries in 12 limbs (Fig 5). Patent SFJ tributaries
were not specifically associated with recurrence of
reflux or varicosities. They were seen in four (27%)
of 15 limbs with recurrence of one or both and in 33
(25%) of 131 limbs without recurrence (P = .90).
SFJ–area connecting veins between the superfi-
cial and deep systems, other than those recognized
as SFJ tributaries with normal prograde flow, were
not observed in either high-ligation groins or groins
without high ligation. This negative finding is con-
ditioned by the fact that a concerted duplex scan-
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Fig 3. Endovenous obliteration. a, Catheter with sheathed electrodes positioned right at the SFJ;
b, compression wrap applied to limb, electrodes expanded spanning the superficial, circumflex, iliac
(SCI) orifice; and c, treatment in progress showing limited contraction of the SCI near its orifice and
long-segment contraction of GSV (wrapping removed to show undistorted anatomy).
ning effort was not made to search for such vessels,
and posttreatment phlebography was not part of the
follow-up.
Principal outcomes. The principal outcome
variables are shown at 6- and 12-month follow-up
intervals in Table IV. At 6 months, CEAP clinical
class and symptom scores were significantly (P =
.0001) improved in both groups, with 86% of high-
ligation limbs and 88% of limbs without high liga-
tion becoming CEAP clinical class 0 or 1. The
magnitude (P = .0001) of CEAP class improvement
was similar in both groups (high ligation, 2.3 → 0.7;
no high ligation, 2.6 → 0.7; P = .151) and sustained
in the 26 high-ligation limbs and 31 limbs without
high ligation followed for 12 months. Twelve-
month symptom scores also remained significantly
(P = .0001) improved in both groups.
Recurrent GSV reflux was identified in one high-
ligation limb in which a limited segment reopening
developed by 6 months. Recurrent reflux was
observed in eight limbs without high ligation: four
had partially recanalized by 3 months, and the other
four showed segmental reopening at 6 months. One
of the limbs that was partially open at 3 months went
on to totally recanalize by 6 months, and the other
three remained stable. Only one newly reopened seg-
ment was observed beyond 6 months. It was a 10-cm
nonrefluxing segment immediately distal to the SFJ
in a limb without high ligation, which was not noted
to have patent SFJ tributaries. Because recurrent
reflux and varicosities are continuing time-variable
hazards, they are best represented as actuarial data,25
as in Fig 7, where it can be seen that reflux recur-
rence follows statistically similar courses in both
groups (P = .157). The data predict greater than 90%
freedom from reflux at 1 year, with lower boundary
95% confidence limits of 94% for high-ligation limbs
and 87% for limbs without high ligation.
At 6 months, three high-ligation limbs and four
limbs without high ligation had recurrent or new
visible varicosities. One additional high-ligation limb
and two more limbs without high ligation had new
varicose veins at 12 months. The recurrent or new
varicosities were typically in the leg, with a few in the
lower thigh. Varicosity recurrence was associated
with limited reopening without reflux in one limb
without high ligation and with recurrent reflux in
four limbs (one with high ligation and three with-
out) and occurred independent of reflux or recanal-
ization in five limbs (three with high ligation and
two without). The actuarial curves of varicose vein
recurrence are shown in Fig 8. They are statistically
similar for both groups (P = .696) and show expec-
tations of greater than 90% freedom from new or
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Fig 4. Color flow duplex scan showing patency of the superficial, circumflex, iliac vein (SCI) within 1
week of treatment, with unimpeded flow through the SFJ into the common femoral vein (CF) and an
otherwise obliterated GSV.
recurrent varicosities at 1 year, with lower boundary
95% confidence limits of 82% for high-ligation limbs
and 88% for limbs without high ligation.
DISCUSSION
Endovenous saphenous vein obliteration with
and without extended SFJ tributary ligation offers a
unique opportunity to study the incremental value of
adding tributary ligation when the thigh portion of
the saphenous vein has been effectively eliminated
from participating in reflux. The results thus far do
not define an important role for SFJ tributary liga-
tion in this setting. Improvements in symptom scores
and CEAP clinical class were significant and persisted
through 12 months with and without high ligation.
The incidences of recurrent reflux and varicosities
were similar between groups and also similar to those
reported in the literature for high ligation with
saphenous stripping in a comparable time frame.13,26
The between-group outcome similarities suggest that
inclusion of high ligation adds little to effective oblit-
eration with three caveats. The first is that the two
cohorts were not randomly allocated. The second is
to note that the between-group comparisons
excluded unsuccessful obliterations, where high liga-
tion, as a double treatment, might have mitigated the
consequences of obliteration failure. Anecdotally, the
single recurrences in each group shown in Fig 2 offer
nothing to support this possibility. The third, and
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Fig 5. Color flow duplex scan showing patency of the superficial, circumflex, iliac (SCI, blue flow) and
the superficial, external, pudendal (SEP, orange flow) veins, which were both initially occluded, with
noncompressible obliteration of the GSV at 6 months. The common femoral vein (CF) flow axis is
perpendicular to the color Doppler scan insonation plane.
Fig 6. Evolving SFJ duplex-scan anatomy in 15 limbs at
various intervals after GSV obliteration.
perhaps most important, caveat is that the data do
not have sufficient power to be negatively conclusive
in the face of the 10% or lower recurrence rates that
have been encountered thus far.
Table V shows the collective data from seven ran-
domized prospective studies of SFJ ligation with and
without GSV stripping, which show that omitting
stripping essentially doubles both the risk of devel-
opment of recurrent reflux and the risk of recurrent
varicose veins over 2 to 5 years.4,7-12 Earlier studies
from two of these centers show that GSV stripping
adds significant recurrent reflux protection, as com-
pared with SFJ ligation without stripping, that is evi-
dent as soon as 3 or 12 months after treatment.13,26
These reported observations are in marked contrast
to what was observed in the current study when SFJ
ligation was or was not added to successful GSV
endovenous obliteration. Together, they suggest
that eliminating the GSV as an actual or potential
reflux conduit is the main component of traditional
ligation and saphenous stripping that affects success.
Reflux recurrence around the SFJ, often associ-
ated with recurrent thigh varicosities, is attributed to
what has been termed inadequate earlier surgery,
meaning persistence of the GSV or missed SFJ trib-
utaries,1,2,12-14 or to neovascularity, which is mani-
fested as newly formed superficial-to-deep and
cross-groin connecting veins.12,13,16 These findings
are clearly associated with recurrent reflux and vari-
cosities, but assigning a causal role to them requires
a modest leap of faith because the presence of
anatomic variants and patent tributaries after high
ligation and stripping has not been systematically
studied in limbs without recurrent clinical pathol-
ogy. The current study provides an opportune venue
to examine this issue. Currently, the incidence of SFJ
tributary patency in limbs followed for 6 months or
longer is essentially identical in limbs with recurrent
reflux or varicose veins and in those without recur-
rent clinical or duplex scanning–detectable pathol-
ogy. Further follow-up and more intensive focus on
the status of tributaries should clarify the clinical
implications of these and other posttreatment SFJ
duplex scanning findings, hopefully, in a manner that
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Table IV. Principal outcome variables in limbs followed for 6 months or longer
Outcome High ligation No high ligation P value
Actual no. at 6 mo 49 (89%) 97 (86%) .633
CEAP clinical class 0.7 ± 1.0 0.7 ± 1.1 .693
Symptom score* 0.2 ± 0.6 0.06 ± 0.3 .024
Recurrent reflux 1 (2%) 8 (8%) .273
Recurrent or new varicosities 3 (6%) 4 (4%) .687
Actual no. at 12 mo 26 (51%) 31 (39%) .207
CEAP clinical class 0.7 ± 0.7 0.8 ± 1.2 .465
Symptom score* 0.3 ± 0.5 0.06 ± 0.25 .073
New recurrent reflux 0 0 1.00
New recurrent varicosities 1 (4%) 2 (7%) 1.00
*One point each for pain, aching-fatigue, and swelling.
Table V. Randomized studies of recurrent truncal vein reflux and varicose veins after high ligation with
and without surgical stripping of the GSV
Limbs or patients Limbs or patients not 
undergoing saphenectomy* undergoing saphenectomy*
Author Follow-up (mo) Recurrent reflux Recurrent varicosities Recurrent reflux Recurrent varicosities
Jakobsen7 36 — 16/158*† — 56/162*
Munn et al8 30-42 — 21/57† — 34/57
Hammarsten et al4 52 ± 5 — 3/24 — 2/18
Sarin et al9 21 21/43† 15/43† 38/46 38/46
Neglén et al10 60 — 30/74 — 53/63
Rutgers and Kitslaar11 36 10/69† 27/69† 34/73 44/73
Dwerryhouse et al12 60 15/52† 11/52 41/58 8/58
Total 21-60 46/164 (28%) 123/477 (26%) 113/177 (64%) 235/477 (49%)
*Patients at follow-up interval; number of limbs treated not specified.
†P < .05 versus same parameter for the high-ligation without saphenectomy group.
will bear extrapolation to the situation after high lig-
ation and saphenectomy.
Persistence of the GSV can occur because the
original operator may have failed to do a true SFJ
ligation and did not remove the GSV.26 However,
an intact “GSV” has been found after some opera-
tions by experienced surgeons who clearly stated in
their operative notes that a saphenous stripping was
performed. The explanation lies in the extraordinary
variability of SFJ and upper saphenous trunk tribu-
taries.27 This is also the principal reason that some
SFJ tributaries are overlooked.1,2,27 Double saphe-
nous veins, usually meaning a large anterolateral or
posteromedial tributary that rejoins the GSV near
the knee, have been reported as being present in
35% of limbs,27 and SFJ tributary patterns show so
much variation that the normal SFJ tributary config-
uration characterizes only a third of limbs.28
Extended SFJ tributary ligation has been pro-
posed as a means of ensuring greater anatomic accu-
racy and raising the barrier against reconnections
between the superficial and deep venous systems.
Completely exposing the fossa ovalis, following each
tributary out to its own first or second tributary, and
sometimes extending the fossa ovalis opening to look
for superficial tributaries that might join the common
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Fig 7. Freedom from recurrent reflux after endovenous obliteration with (filled circles) and without
(open circles) high ligation. Range bars indicate lower 95% confidence limits.
Fig 8. Freedom from new or recurrent varicose veins after endovenous obliteration with (filled circles)
and without (open circles) high ligation. Range bars indicate lower 95% confidence limits.
femoral vein should directly reveal the nature of the
anatomy better than a narrower approach to the SFJ.
However, the concept that wide tributary excision
will make venous reconnections less likely because of
spatial separation may be counterposed by an aggra-
vating influence on new vein formation. Alternate
routes of venous drainage for the superficial tissues of
the lower abdomen and pudendum are not as direct
as those through the SFJ. Obliterating the refluxing
GSV with an incompetent subterminal valve in Fig 9
that is receiving high flow from the superficial exter-
nal pudendal vein would restore physiologic external
pudendal flow through the competent terminal valve
and the SFJ. Ligating the tributary sources would
force their drainage to go elsewhere, potentially stim-
ulating neovascularity or enlargement of existing
small veins, and still require treatment of the GSV to
get at the root cause.
SFJ tributary patency was expected to be more
common after endovenous obliteration without SFJ
ligation than was actually observed in the study. The
obliterative process depends on vein wall collagen
contraction and endothelial destruction over sub-
stantial segments of vein to preclude recanaliza-
tion.18 These changes are applied only to the tribu-
tary orifices and do not extend very far along the
course of the tributary itself, as shown in Fig 3, C,
making reopening far more likely than in the GSV
proper. There was marked disparity between the 6-
month findings of SFJ tributary patency in 14 of 15
carefully studied limbs in one series24 and the 35%
incidence of tributary patency identification in all
groins where high ligation was not part of the pro-
cedure. Similarly, although it might be early to
expect differences in reflux and varicosity recur-
rence, if frustrated abdominal and pudendal superfi-
cial drainage consequent to SFJ-tributary ligation
was to have been a principal stimulant of neovascu-
larity, some evidence of these new vessels could rea-
sonably be anticipated in high-ligation limbs by 6
months. The same would be even more likely if
groin wound healing was a major stimulus. This col-
lective paucity of positive SFJ ultrasound scan find-
ings suggests that follow-up duplex scanning was
typically more focused on the status of the obliter-
ated saphenous vein than on assessing the SFJ for
possible new or persistent superficial-to-deep and
cross-groin connecting veins. Further review of
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Fig 9. High-flow reflux through an incompetent subterminal valve emanating from the superficial,
external, pudendal vein (EP) and, to a lesser extent, from the superficial, circumflex, iliac vein (CI).
Saph, GSV; TV, competent terminal valve, bowed under pressure, during a Valsalva maneuver.
these images seems indicated, but at this point in
time the study has not demonstrated any new vessel
stimulation that could be attributed to SFJ ligation.
In conclusion, this unprecedented opportunity to
examine elimination of a refluxing GSV with and with-
out SFJ ligation has shown no significant advantage or
adverse effect of adding extended SFJ ligation to suc-
cessful endovenous GSV obliteration. GSV oblitera-
tion, with or without SFJ ligation, yielded early reflux
and varicose vein recurrence rates similar to those seen
after high ligation and stripping, with significant and
sustained improvement in symptoms and CEAP clini-
cal class scores through 1 year. These are relatively
early negative findings in a nonrandomized observa-
tional study, lacking sufficient statistical power to
exclude possible between-group differences at the low
recurrence rates that have been observed thus far.
They question the widely held but unproved axiom
that SFJ ligation with branch excision is a necessary
treatment component in achieving the therapeutic
benefits of removing the thigh portion of the GSV but
do not provide a definitive answer. The data should be
interpreted with caution and certainly are not suffi-
ciently robust to warrant abandonment of SFJ ligation,
as currently practiced, in the management of primary
varicose veins associated with GSV vein reflux.
We thank Steven S. Lewis, PhD, of the Medical Data
Coordinating Center for statistical advice and analysis and
William E. Walsh, Jr, for the anatomic illustration.
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DISCUSSION
Dr Harry Schanzer (New York, NY). This paper so
nicely just presented by Dr Chandler tries to evaluate the
need for what he calls “extended high ligation” of the
saphenofemoral junction in the setting of thermally
induced GSV obliteration.
The material of the study consists of 60 limbs that
underwent high ligation and thermal obliteration and
120 limbs that only had thermal obliteration, without
high ligation. The results are that both groups have
equally good significant clinical improvement; there’s no
difference in the incidence of recurrent saphenous reflux
and recurrent varicose veins.
Based on their experience, the authors concluded that
high ligation does not add advantage to the venous oblit-
eration procedure.
This work is very provocative, because it questions the
long- and well-established concept that for a good surgi-
cal result, high ligation with division of all tributaries of
the GSV is essential. If their hypothesis is true, both sur-
gical stripping and obliterative procedures such as sclero-
therapy and thermal obliteration would not need the
addition of high ligation.
I have two problems with this paper: One, this paper
gives great emphasis to recurrence of reflux through the
GSV, due to neovascularization, as a mechanism of vari-
cose vein recurrence. The experience with surgical strip-
ping, nevertheless, has been that the majority of significant
recurrences requiring further treatment, as much as 70%,
are due to incomplete high ligation of the SFJ, with per-
sistence of reflux through the uninterrupted tributaries.
These types of recurrences may take several years before
becoming manifested, and I would not be surprised if in
your patients without high ligation, a third of them hav-
ing patent tributaries, large recurrences developed.
Second, the follow-up is very short. Eighty-four per-
cent of the patients have a follow-up of 6 months, and the
remaining 14% go to a year. It is well known that varicose
recurrences take a long time to appear, and follow-ups of
5 years are essential in order to evaluate conclusively the
quality of any of these therapies.
In conclusion, it is my feeling that until long-term
follow-ups are presented supporting the present hypoth-
esis, high ligation of the GSV should be an integral part
of the treatment of primary varicose veins of the GSV.
I have three questions for Dr Chandler. 
First, are you ready to advise the surgeons that do
“old-fashioned surgical treatment” to perform stripping
and abandon high ligation? 
Second, are you planning to follow up these patients
for up to 5 years? 
Third, in your experience, is the industry involved in
developing new methods for the treatment of varicose
veins ready to support scientifically well-designed prospec-
tive randomized long-term follow-up periods?
I enjoyed very much reviewing and discussing this
provocative and well written paper. I thank the authors for
providing me well ahead of time with the manuscript, and
the Forum for the privilege of discussing it.
Dr James Chandler. The worth of extended saphe-
nofemoral junction ligation is based on a wish to do bet-
ter, not upon evidence that it is an important concomitant
of saphenectomy. I am just raising the question; I cannot
answer it for you today. I do not have evidence to advo-
cate changing what people do, but I do advocate having
an open mind. Heretical thought is always appropriate in
a scientific forum, even on Sunday.
Regarding randomized controlled studies, I believe
that is the way the question will finally be answered, but
recognize that, today, we have only tradition and dogma,
not facts to support the essential nature of extended high
ligation when the thigh position of the GSV has been
effectively eliminated.
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